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Paediatric cardiac surgery for a 
continent – The experience of the Walter 
Sisulu Paediatric Cardiac Centre for Africa
one congenital heart surgeon for 3.5 million individuals, in Africa 
the corresponding figure is one congenital heart surgeon for 
38 million individuals, making Africa the most underserved conti-
nent in terms of congenital heart surgery.(3) To complicate the issue 
further, the treatment costs related to diagnosis and treatment of 
CHD is way beyond the means of the largely indigent population. 
In parts of western Africa, only 20% of the parents of children (less 
than 15 years old) requiring surgery for congenital cardiac disease 
are able to finance the operation within 12 months of diagnosis.(4) 
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IntroductIon                                                               
Congenital heart disease (CHD) is the most common congenital 
birth defect and an important cause of infant mortality.(1) Globally, 
approximately 7% of all neonatal deaths are attributable to major 
congenital malformations, of which at least 25% are due to severe 
forms of congenital heart disease.(1) In the pre-surgical era, less 
than 20% of children born with CHD survived into adulthood.(2) 
The application of the advances made in paediatric cardiology and 
cardiac surgery in the last 50 years now ensures that survival into 
adulthood occurs in 70 to 80% of children born with cardiac disease 
with access to available optimum treatment.(2) This level of care for 
CHD is unavailable in Africa. 
Management of CHD often requires relatively sophisticated diag-
nostic techniques and high-level infrastructure operated by per-
sonnel with advanced training and expertise. The manpower and 
infrastructure required is largely unavailable on the African conti-
nent. While in North America and Europe there is approximately 
Very few African countries have the resources to provide 
optimum paediatric cardiac services to their largely indigent 
populations. In the current era, in countries with access to 
modern paediatric cardiac care, mortality for congenital 
heart disease occurs more often in adulthood than in 
childhood. this level of care is largely unavailable in Africa. 
the Walter sisulu Paediatric cardiac centre for Africa 
was set up in 2003 as a public-private collaborative initiative 
to extend modern paediatric cardiac care to the continent. 
three core functions form the basis of our operations: 
service delivery, training, and research.
this communication reviews our experience with this effort 
over an eight-year period. We have performed 2 023 pro-
cedures on 1 738 patients including a large proportion of 
neonates and infants with an overall mortality of 7.1%. our 
charity arm sponsored 21.5% of these patients. We have 
encountered problems peculiar to the African context which 
we discuss. We also describe innovative techniques in 
management of specific patient populations. our training 
efforts yielded two qualified paediatric cardiac surgeons 
who now work at the centre and two additional surgeons 
are in training. We have participated in research leading to 
publication of papers in peer-reviewed journals. In spite of 
our achievements, we recognise the enormous challenges 
faced by the continent in terms of paediatric cardiac care. 
An attempt has been made to quantify the burden of 
congenital disease in Africa to guide planning and training. 
We offer recommendations on how to address some of 
these pressing health issues for children of the continent. 
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Very few African countries have the resources to provide optimum 
paediatric cardiac care and large numbers of families with CHD lack 
the resources to access the available treatment. South Africa and 
Egypt have the best paediatric cardiac service on the continent and 
yet even in these countries, deficiencies exist. In South Africa, 
where probably the most comprehensive paediatric cardiac pro-
gramme on the continent is housed, less than 40% of the opera-
tions required for CHD are carried out and the infrastructure and 
resources to detect and manage heart disease in children, parti-
cularly within the public sector, are grossly inadequate.(5)
For the rest of the continent, paediatric cardiac care is rather scant. 
In western Africa, Nigeria – the most populous country – performed 
102 cardiac operations between 1974 and 2000.(6) Ghana per-
formed its first open heart procedure, an ASD closure, in 1962 but 
its cardiac programme faltered until 1989. Since then, its National 
Cardiothoracic Centre, the only tertiary cardiothoracic facility in 
the country has been performing an increasing number of open-
heart procedures. The centre currently performs about 400 
cardiothoracic surgical operations annually; a quarter of these are 
cardiac procedures and roughly 75% of cardiac operations are for 
congenital heart disease and rheumatic heart disease. Civil war has 
destroyed much of what Cote d’Ivoire had of an active cardiac 
programme (personal communication F.E.). Paediatric cardiac sur-
gery is also performed by centres in Kenya, Sudan, and Mozambique. 
Altogether, about 2 500 to 3 000 children undergo cardiac surgery 
annually on the African continent(7) (population of over one billion). 
With such a deficiency in comprehensive paediatric cardiac care on 
the continent, there is a clear need for the more resourced 
countries to reach out to the continent’s vast numbers of children 
with no access or funding for paediatric cardiac care.
the WAlter sIsulu PAedIAtrIc cArdIAc              
centre for AfrIcA (WsPccA) 
The problem of a lack of corrective paediatric cardiac surgery on 
the African continent created the impetus to establish the Netcare 
Sunninghill Hospital Paediatric Cardiac Centre for Africa in January 
2003, with three goals: firstly, the creation of a surgical hub to treat 
children with correctable heart disease on the African Continent; 
secondly, mindful of the impossibility of servicing the entire conti-
nent, to offer training and skills development to doctors on the 
African Continent; and, thirdly, to participate in clinical research in 
the African context. The institution was set up under the leader-
ship of the senior author (RHK).
Walter Sisulu was an icon in the apartheid struggle and mentor to 
Nelson Mandela. With Sisulu’s passing in 2003, Mandela considered 
that a true living memory – not a statue – was appropriate for him. 
Consequently, the Netcare Sunninghill Hospital Paediatric Cardiac 
Centre for Africa was renamed the Walter Sisulu Paediatric Cardiac 
Centre for Africa (WSPCCA) with the idea that neonates, infants 
and children from the entire continent, having had congenital heart 
defects corrected at the WSPCCA, would return to their native 
countries and “live the memory” of Walter Sisulu. Its national 
patron Nelson Mandela officially opened the unit on 7 November 
2003, while her Royal Highness Princess Haya Al Hussein, a major 
benefactor, subsequently became the global patron.
While Sunninghill Hospital is the headquarters of the WSPCCA, 
the vision to make the facility national has resulted in operations 
being performed at the Christian Barnard Memorial and the Red 
Cross Children’s War Memorial Hospitals in Cape Town, supported 
by the Walter Sisulu Paediatric Cardiac Foundation (WSPCF). 
Each hospital has a first world unit, operating predominantly in a 
third world environment. At present approximately 85% of pati-
ents are self-funded (medical insurance or personal) and 15% are 
supported by the WSPCF through contributions from donors. In 
addition, in each hospital there is a “rob Peter to pay Paul system” 
whereby donor-funded patients intermingle imperceptibly with 
other patients, without any discrimination while using the same 
facilities.
fulfIllIng the mIssIon – AchIeVements               
Service 
Since its inception in 2003, our programme has performed 2 023 
procedures on 1 738 patients including a large proportion (53%) of 
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neonates and infants under a year old (Figure 1) with an overall 
early mortality of 7.1%. Our outcomes are influenced by the rela-
tively high numbers of neonates and infants, who together account 
for 80% of the overall mortality (Figure 2), a significant number of 
them presenting with co-morbidities such as nutritional problems, 
low birth weight, pre-operative infection, and HIV infection. 
The caseload has grown to over 350 cases per year with a complex 
mix of congenital and acquired cardiac lesions (Figure 3) presenting 
to the centre for diagnosis and treatment. Of these patients, our 
charity arm, the WSPCF funded the care of 373 (21.5%) indigent 
patients extracted from countries across the African continent 
(Figure 4). 
Management policy
For correctable lesions, we favour early complete correction of 
CHD rather than palliation. Peculiar issues have however evolved. 
In the context of our socio-economic background, the spectrum of 
cases seen and the crucial management problems that arise differ 
from the situation in Euro-American centres. These are important 
factors that affect outcomes. Late presentation is an important issue 
that becomes critical in lesions requiring early correction such as 
transposition with intact septum (TGA-IVS), truncus arteriosus, 
atrioventricular canal defect, and others. In truncus arteriosus for 
example, 45% of our patients presented beyond 3 months of age 
and surgical correction was achieved with an early mortality rate of 
18.4%. Similarly, in TGA, the early mortality for all anatomic types 
was 12.5% over the entire period, a figure that has decreased 
markedly over the last 4 years.(8)
Technical innovations
In dealing with the issue of late presentation, we have had to modify 
our management approach. This is especially pertinent to the infant 
with TGA-IVS. With the advances made in paediatric mechanical 
circulatory support, we modified our policy on the treatment of 
TGA-IVS from August 2006. We adopted a policy of extending the 
age limit of the primary arterial switch operation up to 10 weeks of 
age, with mechanical circulatory support as a stand-by rescue. We 
have reported(8) results for the primary arterial switch for TGA-IVS 
in patients 3 to 10 weeks of age comparable to those younger than 
3 weeks of age. 
We have developed a method of optimal exposure of the subaortic 
region for the transaortic approach to lesions such as discrete 
subaortic stenosis, subaortic VSD, and hypertrophic obstructive 
cardiomyopathy. The hexagonal six-point traction technique(9) 
facilitates exposure of the subaortic region with minimal use of 
metallic retractors. Our results with this technique in the last 39 
consecutive procedures evaluated have been good: early mortality 
of 2.6% (1 death) with a mean cross-clamp time of 38.4±16.4 
minutes. 
We performed a total of nine Mustard operations in the period 
primarily for late presenting transpositions. By extending our age 
limit for the primary arterial switch operation to the first ten weeks 
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fIgure 1: Age distribution of patients. Neonates (less than 1 
month old), infants (1 to 12 months old), children (1 to 18 years 
old), adults (more than 18 years old). 
Age distribution
Children
43% Infants
38%
Neonates
15%
Adults
4%
fIgure 2: Mortality distribution for the various age groups.
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of life,(8) Mustard operations have been performed less frequently 
since August 2006.
With the advances made in paediatric mechanical circulatory 
support, we have operated on all children referred with anomalous 
left coronary artery from the pulmonary artery (ALCAPA) regard-
less of the left ventricular (LV) function. In reconstructing the main 
pulmonary artery, we employ glutaraldehyde-treated autologous 
pericardium for pulmonary root augmentation to avoid tension on 
the anastomosis, stretching, and compression of the relocated 
coronary artery. We have obtained excellent results with this ap-
proach with a left ventricular assist device (LVAD) on standby to 
rescue poor LVs (lowest preoperative fractional shortening of 
6%). The postoperative salvage rate using LVAD for post-cardio-
tomy LV failure in this patient population has been 85.7% (6 out 
of 7) in our experience.
fIgure 3: Specific procedures performed.
A-P: aortopulmonary, IAA: interrupted aortic arch, ALCAPA: anomalous left coronary artery from the pulmonary artery, DORV: double outlet right ventricle, ECMO: extracorporeal membrane 
oxygenation, TAPVD: total anomalous pulmonary venous drainage, PAB: pulmonary artery band, PV: pulmonary valve, PM: pacemakers, AV procedures: aortic valve procedures, TGA: transposition 
of great arteries, ASO: arterial switch operation, MV: mitral valve, AV Canal: atrioventricular canal, ASD: atrial septal defect, PDA: patent ductus arteriosus, VSD: ventricular septal defect.
A-P Window
Truncus+IAA
Supravalvar aortic stenosis
Mustard
ALCAPA
Truncus
IAA
DORV
Norwood type repair
ECMO/ASSIST
TAPVD
Conduit replacements
Fontan (extracardiac)
PAB
Subaortic obstructions
PV procedures
Glenn’s
PM
AV procedures
Shunts
TGA (ASO & Rastelli)
MV procedures
AV Canal
ASD
Coarctation
PDA (Isolated)
Tetralogy
Miscellaneous
VSD
0 50 100 150 200 250 300
126
PAEdiATriC CArdiAC SurgEry
In repair of primary coarctation, we favour the use of patch 
aortoplasty employing oversized patches fashioned from Gore-Tex 
tube grafts (from 6mm for the neonate). Aneurysms have been 
rare in our experience and the recurrence rate over the period 
has been satisfactory at 6.5% (6 of the last 92 procedures) which 
compares favourably with a recent report.(10) 
Our right ventricle to pulmonary artery (RV-PA) conduit replace-
ment technique has evolved to our currently favoured approach 
of aortic transection with maximal exposure of the right ventri-
cular outflow tract (RVOT) and pulmonary artery confluence and 
branches. We employ a retrograde takedown technique after 
which the new conduit is implanted. We elongate the aorta with a 
short appropriate-sized Dacron graft to relieve pressure on the 
implanted conduit.
  
Our policy for single ventricle repair currently involves early (6-9 
months) bi-directional Glenn shunt and a low threshold to taking 
down failed Glenn and Fontan repairs. Our results for the Norwood 
procedure have not been satisfactory (30% hospital survival). 
Perhaps no lesion demonstrates the vital importance of a compre-
hensive approach to management of CHD better than hypoplastic 
left heart syndrome (HLHS). This is one area we need to improve 
upon in the coming years. 
The availability of mechanical circulatory support for our patients 
has made a positive contribution to our results. This is clearly the 
case in the management of the child with ALCAPA where the 
salvage rate is in excess of 85% for patients with post-cardiotomy 
LV failure. 
Rheumatic heart disease is still a scourge on the continent and most 
patients present late. There are two primary pathological proces-
ses in children with rheumatic heart disease – valvulitis and annular 
dilatation. All other valve pathology occur secondary to these 
processes. Repair is favoured whenever possible; valve replace-
ment is reserved for patients in whom repair fails. Valve repair is 
tailored to the pathological findings at the time of operation. For 
example, a mitral valve ring is inserted to restore the shape and size 
of the mitral annulus. Secondary changes are treated accordingly. 
We believe that the prevalence of rheumatic heart disease in Africa 
is unacceptable and every effort must be made by governments and 
indeed all stakeholders to ensure that preventive guidelines are 
followed.
Training
We began our training programme by enlisting two locally trained 
surgeons in 2004, for further training in paediatric cardiac surgery. 
These have since become fully-fledged paediatric cardiac surgeons 
fIgure 4: Countries served by WSPCCA from 2003-2010. 
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on the WSPCCA team and have taken up the task of training 
others. 
Our next two trainees joined in 2009, one from South Africa and 
the other from Ghana. Both are cardiothoracic surgeons seeking 
further training in paediatric cardiac surgery and they are close to 
completing a two-year programme in paediatric cardiac surgery. 
Typically teaching at the WSPCCA is through the efforts of highly 
trained staff members and consists of daily early morning ward 
rounds reviewing all patient data. The surgical and cardiology teams 
are accompanied by a paediatric pulmonologist, microbiologist, and 
a nutritionist. Weekly cardiology meetings with discussion of echo-
cardiograms and angiograms, weekly surgical meetings including a 
monthly morbidity and mortality meeting complement the learning 
programme. Operative technique is taught during surgery and 
discussions of alternate surgical approaches are encouraged. In this 
manner we hope to train African surgeons for the African conti-
nent who will take their skills back to their home countries. 
In 2008, we introduced our international paediatric cardiac sympo-
sium as a learning forum for paediatric cardiac surgeons and 
cardiologists on the continent. The symposium, which in terms of 
attendance has outgrown its original venue at the Sunninghill 
Hospital, has become a popular gathering for both local and 
international experts. It has attracted distinguished leaders in the 
field such as Christo Tchervenkov and Giovanni Stellin (2008), 
Richard Ohye and Christian Schreiber (2009), Richard Jonas, 
Christian Brizard, Christopher Knott-Craig and Christian Schreiber 
(2010). The proceedings of the 2010 symposium were reported in 
the World Journal for Paediatric and Congenital Heart Surgery.(11)
We have also established a yearly skills exchange programme for 
our clinical personnel (surgeons, cardiologists, anaesthesiologists, 
perfusionists, and nurses) with centres in Germany, the UK, and 
the US. We continue to learn from their experiences shared in 
their reports on return.
     
research
Research in Africa is often relegated to an extremely low priority. 
In the midst of the several pressing socio-economic challenges 
facing the continent, research receives sponsorship primarily for 
diseases like malnutrition, diarrhoea, tuberculosis, and HIV. Cardio-
vascular research in many African countries receives hardly any 
sponsorship. Not surprisingly, the contribution of Africa to global 
cardiovascular research in the number of published articles be-
tween 1995 to 2002, was estimated in one report to be 0.3%.(12) 
In the same study period, the report suggested that developing 
world regions, with the important exception of Africa, achieved 
an increasing rate in the number of published articles. It would 
appear that in Africa, we are close to fulfilling the words of Albert 
Starr: “… practicing surgery in an intellectual vacuum”.(13) Much 
remains to be done in the field of cardiovascular research in Africa 
if we are to overcome our peculiar healthcare challenges.
We have embarked on cardiovascular research in partial fulfil- 
ment of our mission. Our research activities have led to several 
publications(8,9,11,14-17) in peer-reviewed journals. We continue to 
embark on research in other areas.
the chAllenge of PAedIAtrIc cArdIAc             
surgery In AfrIcA
We have made satisfactory progress in the three areas that 
constitute our core mission – service, training, and research. How-
ever, our achievements pale in the light of the enormous chal-
lenges confronting the continent in the area of paediatric cardiac 
services. Fundamental to our continent’s problem is the fact that 
we must practice with very little scientific data. Rheumatic heart 
disease continues to plague most African nations with no sign of 
abatement. The incidence of rheumatic fever in Africa may be as 
high as 30.4 per 1 000 in schoolchildren.(18) The burden of congenital 
heart disease in Africa is not known and so determining the 
manpower and infrastructure required to adequately confront this 
challenge must be based on conjecture. The United Nations 
Department of Economic and Social Affairs(19) estimate Africa’s 
population at end of 2010 to be in excess of 1 billion, which con-
stituted 15% of the world’s population. Despite regional variations 
in environmental factors and genetic makeup, the incidence of 
congenital heart disease around the world remains consistent at 
approximately 0.8% of live births.(20) Considering the fact that Africa 
can only boast of roughly 1% of the global pool of cardiothoracic 
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surgeons,(21) this is indeed a heavy burden, Hart’s inverse care law(22) 
“the availability of good medical care tends to vary inversely with 
the need for it in the population served” would apply to much of 
Africa. It is our conviction that by providing an avenue for training 
of cardiovascular specialists, surgical hubs can be established in the 
regions of Africa where cardiovascular services are most needed 
but least available.
We infer from our experience that four primary obstacles must be 
overcome to enable progress in paediatric cardiac service delivery 
in Africa. These obstacles are in the area of manpower development, 
infrastructural layouts, healthcare financing, and staff retention 
programmes. 
Personnel development
Personnel development involves selection and training of appro-
priate cardiovascular teams to deliver diagnostic and therapeutic 
services to their populations. Already established centres of excel-
lence on the continent can help by providing training opportunities 
to personnel from deprived regions of the continent. 
Healthcare infrastructure
Cardiovascular care unfortunately requires a heavy financial outlay 
to provide the necessary physical structures that make healthcare 
delivery efficient and safe. Gross national product (GNP) in Africa 
is less than $1 800 per inhabitant per year compared to between 
$24 000 to $31 000 in North America and Western Europe.(21) The 
worldwide distribution of cardio-thoracic surgeons very closely 
follows the distribution of GNP,(21) a testament to the fact that 
cardiothoracic surgery requires a solid infrastructural basis to 
practice. 
In this regard, the adoption of the concept of regionalisation may 
be helpful. Regionalisation of cardiac care is the process of creating 
and maintaining a comprehensive, coordinated cardiac programme 
to provide care to a region or population of patients.(23) Population 
and birth rate data can guide the geographical location of such 
treatment hubs to balance optimal care and travel distances for 
families. Such an approach requires the combined commitment of 
cardiovascular specialists, health institutions, and governments. 
Healthcare financing
Healthcare financing continues to be a thorny issue for most 
developing countries. State health insurance is non-existent in most 
African countries and most insurance schemes in Africa, if they exist 
at all, do not cover paediatric cardiac surgery. Financing paediatric 
cardiac surgery is thus left on the feeble shoulders of the largely 
indigent affected families. Occasionally philanthropic organisations, 
charitable individuals, public appeals for funds, and subsidies from 
healthcare institutions become the mode of financing the near-
terminal child. Until African governments improve the economies 
of their countries, it appears the African child with CHD will 
continue to depend on the benevolence of others for care. The 
WSPCCA model is helpful and we recommend it, but in the long 
term, Africans must be economically empowered to solve their 
own healthcare problems. 
retention of trained staff
In the absence of adequate remuneration and infrastructural lay-
outs, trained cardiovascular specialists will tend to drift to regions of 
the world where these conditions are met. The brain drain syn-
drome is a perennial problem and poor countries are forever losing 
their “brains” to rich ones. This however must not serve as an 
excuse for African governments not to invest in training their own 
staff. There are no simple solutions to the brain drain syndrome in 
Africa. “Push” and “pull” factors have been described(24) to 
characterise the dynamics of this phenomenon but it appears the 
gross economic and political differences between Africa and the 
developed world has established gradients that only facilitate Africa 
losing its brains.
 
conclusIons                                                                 
The Walter Sisulu Paediatric Cardiac Centre’s experience shows a 
promising public-private collaboration model that may be repro-
duced in the fashion of regionalisation to serve the African popu-
lation in terms of much needed paediatric cardiac services.
CHD in Africa accounts for a sizable proportion of the global CHD 
burden and yet has only 1% of the world’s population of cardio-
thoracic surgeons. Centres of excellence on the continent can help 
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relieve this burden by offering training opportunities to Africans in 
the most deprived regions of the continent.
It is feasible for African cardiovascular specialists to undertake care 
of the child with serious forms of heart disease on the continent 
with acceptable results.
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